Lataa...
Development of Neuropeptide Drugs that Cross the Blood-Brain Barrier
Summary: In recent years, there have been several important advancements in the development of neuropeptide therapeutics. Nevertheless, the targeting of peptide drugs to the CNS remains a formidable obstacle. Delivery of peptide drugs is limited by their poor bioavailability to the brain due to low...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
The American Society for Experimental NeuroTherapeutics, Inc.
2005
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC539319/ https://ncbi.nlm.nih.gov/pubmed/15717056 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|